Catherine M Warnement1, Mary J Cismowski2, Lynette K Rogers3. 1. Center for Perinatal Research, Abigail Wexner Research Institute at Nationwide Children's Hospital, USA. 2. Center for Cardiovascular Research, Abigail Wexner Research Institute at Nationwide Children's Hospital, USA; Department of Pediatrics, The Ohio State University, USA. 3. Center for Perinatal Research, Abigail Wexner Research Institute at Nationwide Children's Hospital, USA; Department of Pediatrics, The Ohio State University, USA. Electronic address: lynette.rogers@nationwidechildrens.org.
Abstract
AIMS: MicroRNAs (miRs) and their importance in development, normal physiology, and disease have become increasingly recognized. Our laboratory is interested in miR-29 and its effects on lung development. These studies set out to identify optimal conditions for the measurement of miR-29 in heparinized, biobanked samples and to compare isoform expression patterns. MATERIALS AND METHODS: The efficiency of three distinct heparinases were tested using reverse transcriptase polymerase chain reaction (RT-PCR): recombinant F. Heparinum heparinase I; recombinant P. heparinus heparinase II; recombinant P. heparinus heparinase III; and heparinase I (B. efferthii-derived). The effects of freeze/thaws, and the relative expression of different miR-29 isoforms were also assessed using RT-PCR. KEY FINDINGS: Our investigations determined that heparinase 1 (recombinant F. Heparinum) and 2 (recombinant P. heparinus) at 1 or 2 h incubation efficiently neutralized heparin activity and prevented interference with the PCR. Also, a single freeze/thaw did not affect the measurement of miR-29-3p but multiple freeze/thaw cycles decreased the measureable miR levels. Finally, the -3p strand was most abundantly expressed in all three isoforms in both human and mouse plasma. SIGNIFICANCE: Our findings illustrate that specific conditions need to be optimized for the particular miR and the type of sample being tested.
AIMS: MicroRNAs (miRs) and their importance in development, normal physiology, and disease have become increasingly recognized. Our laboratory is interested in miR-29 and its effects on lung development. These studies set out to identify optimal conditions for the measurement of miR-29 in heparinized, biobanked samples and to compare isoform expression patterns. MATERIALS AND METHODS: The efficiency of three distinct heparinases were tested using reverse transcriptase polymerase chain reaction (RT-PCR): recombinant F. Heparinum heparinase I; recombinant P. heparinus heparinase II; recombinant P. heparinus heparinase III; and heparinase I (B. efferthii-derived). The effects of freeze/thaws, and the relative expression of different miR-29 isoforms were also assessed using RT-PCR. KEY FINDINGS: Our investigations determined that heparinase 1 (recombinant F. Heparinum) and 2 (recombinant P. heparinus) at 1 or 2 h incubation efficiently neutralized heparin activity and prevented interference with the PCR. Also, a single freeze/thaw did not affect the measurement of miR-29-3p but multiple freeze/thaw cycles decreased the measureable miR levels. Finally, the -3p strand was most abundantly expressed in all three isoforms in both human and mouse plasma. SIGNIFICANCE: Our findings illustrate that specific conditions need to be optimized for the particular miR and the type of sample being tested.
Authors: Thorarinn Blondal; Søren Jensby Nielsen; Adam Baker; Ditte Andreasen; Peter Mouritzen; Maria Wrang Teilum; Ina K Dahlsveen Journal: Methods Date: 2012-10-02 Impact factor: 3.608
Authors: Lynette K Rogers; Mary Robbins; Duaa Dakhlallah; Zhaogang Yang; L James Lee; Madison Mikhail; Gerard Nuovo; Gloria S Pryhuber; Gerald McGwin; Clay B Marsh; Trent E Tipple Journal: Ann Am Thorac Soc Date: 2015-10
Authors: Maria Angelica Cortez; Carlos Bueso-Ramos; Jana Ferdin; Gabriel Lopez-Berestein; Anil K Sood; George A Calin Journal: Nat Rev Clin Oncol Date: 2011-06-07 Impact factor: 66.675
Authors: Shaheen Durrani-Kolarik; Caylie A Pool; Ashley Gray; Kathryn M Heyob; Mary J Cismowski; Gloria Pryhuber; L James Lee; Zhaogang Yang; Trent E Tipple; Lynette K Rogers Journal: Am J Physiol Lung Cell Mol Physiol Date: 2017-05-04 Impact factor: 5.464
Authors: Markus Velten; Rodney D Britt; Kathryn M Heyob; Stephen E Welty; Britta Eiberger; Trent E Tipple; Lynette K Rogers Journal: Am J Physiol Regul Integr Comp Physiol Date: 2012-06-20 Impact factor: 3.619